JP2022515884A5 - - Google Patents

Info

Publication number
JP2022515884A5
JP2022515884A5 JP2021538386A JP2021538386A JP2022515884A5 JP 2022515884 A5 JP2022515884 A5 JP 2022515884A5 JP 2021538386 A JP2021538386 A JP 2021538386A JP 2021538386 A JP2021538386 A JP 2021538386A JP 2022515884 A5 JP2022515884 A5 JP 2022515884A5
Authority
JP
Japan
Prior art keywords
independently
integer
group
bond
value
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021538386A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022515884A (ja
JP7657152B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/000018 external-priority patent/WO2020141459A1/en
Publication of JP2022515884A publication Critical patent/JP2022515884A/ja
Publication of JP2022515884A5 publication Critical patent/JP2022515884A5/ja
Priority to JP2024178721A priority Critical patent/JP2025020143A/ja
Application granted granted Critical
Publication of JP7657152B2 publication Critical patent/JP7657152B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021538386A 2019-01-03 2020-01-03 切断可能なリンカーを含む化合物及びその使用 Active JP7657152B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024178721A JP2025020143A (ja) 2019-01-03 2024-10-11 切断可能なリンカーを含む化合物及びその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962788013P 2019-01-03 2019-01-03
US62/788,013 2019-01-03
PCT/IB2020/000018 WO2020141459A1 (en) 2019-01-03 2020-01-03 Compounds comprising cleavable linker and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024178721A Division JP2025020143A (ja) 2019-01-03 2024-10-11 切断可能なリンカーを含む化合物及びその使用

Publications (3)

Publication Number Publication Date
JP2022515884A JP2022515884A (ja) 2022-02-22
JP2022515884A5 true JP2022515884A5 (https=) 2023-01-19
JP7657152B2 JP7657152B2 (ja) 2025-04-04

Family

ID=71407393

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021538386A Active JP7657152B2 (ja) 2019-01-03 2020-01-03 切断可能なリンカーを含む化合物及びその使用
JP2024178721A Withdrawn JP2025020143A (ja) 2019-01-03 2024-10-11 切断可能なリンカーを含む化合物及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024178721A Withdrawn JP2025020143A (ja) 2019-01-03 2024-10-11 切断可能なリンカーを含む化合物及びその使用

Country Status (11)

Country Link
US (1) US20220118104A1 (https=)
EP (1) EP3906064A4 (https=)
JP (2) JP7657152B2 (https=)
KR (1) KR20210099660A (https=)
CN (2) CN114306634A (https=)
AU (1) AU2020205160A1 (https=)
BR (1) BR112021012365A2 (https=)
CA (1) CA3124758A1 (https=)
EA (1) EA202191854A1 (https=)
MX (1) MX2021008095A (https=)
WO (1) WO2020141459A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120682290A (zh) 2017-07-04 2025-09-23 尹图赛利有限公司 包含可裂解接头的化合物及其用途
KR20210099658A (ko) 2019-01-03 2021-08-12 주식회사 인투셀 절단가능 링커를 포함하는 화합물 및 이의 용도
WO2020232247A1 (en) 2019-05-14 2020-11-19 Provention Bio, Inc. Methods and compositions for preventing type 1 diabetes
IL298999A (en) 2020-06-11 2023-02-01 Provention Bio Inc Methods and compositions for the prevention of type 1 diabetes
JP2024520444A (ja) 2021-05-24 2024-05-24 プロヴェンション・バイオ・インコーポレイテッド 1型糖尿病を治療するための方法
WO2025237246A1 (en) * 2024-05-11 2025-11-20 Westlake Laboratory Of Life Sciences And Biomedicine Novel covalent protein and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3092256T3 (da) * 2014-01-10 2022-06-20 Birdie Biopharmaceuticals Inc Forbindelser og sammensætninger til immunterapi
KR101628872B1 (ko) * 2014-05-28 2016-06-09 주식회사 레고켐 바이오사이언스 자가-희생 기를 포함하는 화합물
CN107922375B (zh) * 2015-07-30 2020-05-22 正大天晴药业集团股份有限公司 靶向idh2突变的抗肿瘤化合物及其使用方法
KR101766822B1 (ko) * 2015-09-10 2017-08-24 서울대학교산학협력단 디페닐설페이트 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 c형 간염 바이러스 관련 질환의 예방 또는 치료용 약학적 조성물
WO2018124758A2 (ko) * 2016-12-28 2018-07-05 주식회사 인투셀 베타-갈락토사이드가 도입된 자가-희생 기를 포함하는 화합물
CN120682290A (zh) 2017-07-04 2025-09-23 尹图赛利有限公司 包含可裂解接头的化合物及其用途
MX2020012718A (es) 2018-05-29 2021-02-16 Intocell Inc Derivados de benzodiazepinas novedosos y usos de los mismos.
CN112930350A (zh) 2018-10-31 2021-06-08 尹图赛利有限公司 稠合杂环苯并二氮杂䓬衍生物及其用途

Similar Documents

Publication Publication Date Title
JP2022515884A5 (https=)
JP2022515885A5 (https=)
JP2020527599A5 (https=)
CN108290944B (zh) 载体结合剂组合物及其制备和使用方法
US7364859B2 (en) Methods of using bioelastomers
KR20180030993A (ko) 항체-약물 접합체 중의 공유결합 링커 및 이의 제조방법 및 사용방법
KR20200041914A (ko) 면역자극제 톨-유사 수용체 7 (tlr7) 효능제로서의 6-아미노-7,9-디히드로-8h-퓨린-8-온 유도체
JPS59116229A (ja) 細胞毒性複合体を活性成分とする癌治療用剤およびその製造法
JP3669752B2 (ja) 診断用マーカー
CN102614521A (zh) 利用白蛋白-结合蛋白作为靶标的治疗方法
CN112204039A (zh) 荧光性化合物及使用了该荧光性化合物的荧光标记生物物质
JP7799329B2 (ja) センシング用ナノ粒子及びその製造方法
WO2013043902A1 (en) Targeted nanoparticles joined to reporter molecules through multiple mechanisms
CN113490678A (zh) 荧光gtp类似物和用途
JPH0561279B2 (https=)
WO2004043492A1 (en) Method for the selective and quantitative functionalization of immunoglobulin fab fragments, conjugate compounds obtained with the same and compositions thereof
US11975074B2 (en) Photodynamic therapy composition
EP3531132B1 (en) Kit for measuring substance to be measured, fluorescent labeling agent, and fluorescently labeled antibody
JP2007512324A (ja) Erb抗原のターゲッティング
CN120936679A (zh) 苯并噻吩并吡咯花菁染料
US10114014B2 (en) Macromolecular conjugates for isolation, immobilization and visualization of proteins
Bernier et al. A chlorambucil-anti-CEA conjugate cytotoxic for human colon adenocarcinoma cells in vitro
RU2020104697A (ru) Соединения, содержащие расщепляемый линкер, и способы их применения
CN112969478B (zh) 可滤过的含倍癌霉素抗体-药物缀合物组合物及相关方法
JP2025507736A (ja) 投薬レジメン